CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,252,017 | -24.9% | 93,156 | -7.4% | 0.80% | -18.1% |
| Q1 2023 | $1,667,815 | -9.9% | 100,592 | +1.0% | 0.97% | -12.0% |
| Q4 2022 | $1,851,872 | +46.0% | 99,563 | +0.7% | 1.10% | +25.7% |
| Q3 2022 | $1,268,000 | +14.1% | 98,840 | -37.6% | 0.88% | +17.2% |
| Q2 2022 | $1,111,000 | -15.4% | 158,473 | 0.0% | 0.75% | +0.9% |
| Q1 2022 | $1,314,000 | +28.2% | 158,473 | +4.7% | 0.74% | +34.2% |
| Q4 2021 | $1,025,000 | +27.8% | 151,384 | 0.0% | 0.55% | +17.9% |
| Q3 2021 | $802,000 | – | 151,384 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |